RxDoctor Payments Data

Christopher Toth

Podiatrist · Biddeford, MENPI 1659479541

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (43.2%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. Medical Device Business Services, Inc. accounts for 62.3% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2019 at $7,596 and has fallen 87.9% since, to $921 in 2025. Among podiatrist clinicians in ME with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,160in general payments, 2019–2025

Across 50 payments — averaging $203.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$6K
  • Treace Medical Concepts, Inc.$1K
  • Zimmer Biomet$1K
  • Arthrosurface Incorporated$746
  • Johnson & Johnson$104
  • Nextremity Solutions Inc.$82
  • plus $232 from 6 others

What the payments were for

  • Consulting fees$4,27542%
  • Travel & lodging$4,38843%
  • Food & beverage$1,49815%

General payments by program year

19
20
21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,160 in reported general payments places this provider in the 95th percentile of 20 podiatrist providers in Maine.

See all podiatrist providers in Maine

Medicare billing

Part B allowed, 2024
$77,622
Medicare patients
207
Services billed
789

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naloxone Hcl11$581
Oxycodone Hcl81$242
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav17$195
Cephalexin28$195

Paid to pharmacies, not to this prescriber.

Other podiatrist in Biddeford

See the full list for Maine

Where these figures come from

Is this you, or does something look wrong? →